[go: up one dir, main page]

AR008474A1 - Derivado de 9-dihidroeritromicina a 6,9; 11,12-diciclocarbonato, composicion farmaceutica y preparacion bactericida que lo contienen y su uso - Google Patents

Derivado de 9-dihidroeritromicina a 6,9; 11,12-diciclocarbonato, composicion farmaceutica y preparacion bactericida que lo contienen y su uso

Info

Publication number
AR008474A1
AR008474A1 ARP970104338A ARP970104338A AR008474A1 AR 008474 A1 AR008474 A1 AR 008474A1 AR P970104338 A ARP970104338 A AR P970104338A AR P970104338 A ARP970104338 A AR P970104338A AR 008474 A1 AR008474 A1 AR 008474A1
Authority
AR
Argentina
Prior art keywords
dihydroerythromycin
derivative
diciclocarbonato
contain
pharmaceutical composition
Prior art date
Application number
ARP970104338A
Other languages
English (en)
Original Assignee
Taiwho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiwho Pharmaceutical Co Ltd filed Critical Taiwho Pharmaceutical Co Ltd
Publication of AR008474A1 publication Critical patent/AR008474A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

Un derivado de 9-dihidroeritromicina A 6,9; 11,12-diciclocarbonato caracterizado por la formula (I).
ARP970104338A 1996-09-24 1997-09-22 Derivado de 9-dihidroeritromicina a 6,9; 11,12-diciclocarbonato, composicion farmaceutica y preparacion bactericida que lo contienen y su uso AR008474A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP25105096 1996-09-24

Publications (1)

Publication Number Publication Date
AR008474A1 true AR008474A1 (es) 2000-01-19

Family

ID=17216881

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970104338A AR008474A1 (es) 1996-09-24 1997-09-22 Derivado de 9-dihidroeritromicina a 6,9; 11,12-diciclocarbonato, composicion farmaceutica y preparacion bactericida que lo contienen y su uso

Country Status (7)

Country Link
US (1) US5804565A (es)
JP (1) JP2001500895A (es)
AR (1) AR008474A1 (es)
AU (1) AU4222797A (es)
CO (1) CO4950559A1 (es)
WO (1) WO1998013373A1 (es)
ZA (1) ZA978546B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1351608A (zh) 1999-05-24 2002-05-29 辉瑞产品公司 13－甲基红霉素衍生物
US20020115621A1 (en) * 2000-08-07 2002-08-22 Wei-Gu Su Macrolide antibiotics
WO2004101592A1 (ja) * 2003-05-19 2004-11-25 Taisho Pharmaceutical Co., Ltd. エリスロマイシンａ誘導体の製造方法
HRP20100253T1 (hr) 2004-12-21 2010-06-30 Pfizer Products Inc. Makrolidi
AR085286A1 (es) * 2011-02-21 2013-09-18 Taisho Pharmaceutical Co Ltd Derivado de macrolido sustituido en la posicion c-4

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4331803A (en) * 1980-06-04 1982-05-25 Taisho Pharmaceutical Co., Ltd. Novel erythromycin compounds
JPH0633312B2 (ja) * 1986-05-02 1994-05-02 大正製薬株式会社 １４−ハイドロキシエリスロマイシン誘導体およびその製造方法
KR960000434B1 (ko) * 1986-12-17 1996-01-06 다이쇼 세이야꾸 가부시끼가이샤 에리스로마이신 a유도체 및 그의 제조 방법
IL114589A (en) * 1990-11-21 1999-12-22 Roussel Uclaf Intermediates for the preparation of erythromycin derivatives
KR0166096B1 (ko) * 1990-11-28 1999-01-15 우에하라 아키라 6-0-메틸에리쓰로마이신 a 유도체
US5523399A (en) * 1991-12-27 1996-06-04 Taisho Pharmaceutical Co., Ltd. 5-O-desosaminylerythronolide derivatives
FR2692579B1 (fr) * 1992-06-19 1995-06-02 Roussel Uclaf Nouveaux dérivés de la picromycine, leur procédé de préparation et leur application comme médicaments.
US5393743A (en) * 1993-07-06 1995-02-28 Abbott Laboratories Erythromycin derivatives

Also Published As

Publication number Publication date
ZA978546B (en) 1998-04-01
AU4222797A (en) 1998-04-17
US5804565A (en) 1998-09-08
JP2001500895A (ja) 2001-01-23
WO1998013373A1 (en) 1998-04-02
CO4950559A1 (es) 2000-09-01

Similar Documents

Publication Publication Date Title
ES2195970T3 (es) L-ribavirina y usos de la misma.
CL2004001102A1 (es) Compuestos derivados de 2-amino-4-bicicloamino-1,3,5-triazinas; composicion herbicida que los contiene; procedimiento de preparacion; uso de dichos compuestos; y compuestos intermediarios.
ES2114487B1 (es) Mezcla estabilizante sinergistica.
PT1413582E (pt) Pirrolobenzodiazepinas dimericas
PT960107E (pt) Compostos de paclitaxel 6-tio-substituidos
MX9304581A (es) Desoxitaxoles y composiciones farmaceuticas que los contienen
DK0695171T3 (da) Lyosfærer indeholdende gonadotropin
MX9804588A (es) Uso de composiciones que comprenden blanqueador de halogeno para suavidad mejorada a la piel.
IT1293778B1 (it) 1,4,7,10-tetraazabiciclo(8.2.2.)tetradecan-2 one, sua preparazione e suo uso per la preparazione di tetraazamacrocicli
IT1231012B (it) Composizione farmaceutica per uso orale contenente nac.
MX9200731A (es) Compuestos de hidrazona, procedimientos para su prcompuestos de hidrazona, procedimientos para su preparacion, compuestos intermedios utiles para su oeparacion, compuestos intermedios utiles para suobtencion y composiciones pesticidas que contienena btencion y composiciones pesticidas que contienenalos mismos. los mismos.
ES2171018T3 (es) Uso de agentes inmunomoduladores.
MX9604765A (es) Derivados de 5-heterociclico 1,5-benzodiazepinas que modulan la cck o gastrina.
DK0842165T3 (da) Thiazolidin-4-carboxylsyrederivater som cytobeskyttende midler
KR960703863A (ko) 암 치료용 신규 비스-나프탈이미드(New Bis-naphthalimides for the Treatment of Cancer)
MX9704034A (es) Derivados y composiciones de 1,1-dioxido de 2-arilcarboniloximetil-1,2,5-tiadiazolidin-3-ona substituido y metodo de uso.
BR9814495A (pt) Composto, processo para prepará-lo, uso do mesmo, composição farmacêutica, e, processo
ES2105605T3 (es) Antagonistas de taquiquinina, su preparacion y utilizacion en formulaciones farmaceuticas.
MY127474A (en) Naphthyl compounds, intermediates, compositions, and methods of use
AR008474A1 (es) Derivado de 9-dihidroeritromicina a 6,9; 11,12-diciclocarbonato, composicion farmaceutica y preparacion bactericida que lo contienen y su uso
DK1073447T3 (da) N1-modificerede glycopeptider
ES2179375T3 (es) Composiciones farmaceuticas estabilizadas, a base de quinupristina y de dalfopristina y su preparacion.
NO923266L (no) Heksahydrobenzo(f)quinolinoner
EA200000112A1 (ru) Новая композиция
ES2175661T3 (es) Derivados de la isoflavona, procedimientos para la preparacion de los mismos y composiciones farmaceuticas que los contienen.